Log in to save to my catalogue

The EMIF-AD PreclinAD study: study design and baseline cohort overview

The EMIF-AD PreclinAD study: study design and baseline cohort overview

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1550fd3ad24a4070bf47c772e48b117e

The EMIF-AD PreclinAD study: study design and baseline cohort overview

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Amyloid pathology is the pathological hallmark in Alzheimer's disease (AD) and can precede clinical dementia by decades. So far it remains unclear how amyloid pathology leads to cognitive impairment and dementia. To design AD prevention trials it is key to include cognitively normal subjects at high risk for amyloid pathology and to find predictors...

Alternative Titles

Full title

The EMIF-AD PreclinAD study: study design and baseline cohort overview

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1550fd3ad24a4070bf47c772e48b117e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1550fd3ad24a4070bf47c772e48b117e

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-018-0406-7

How to access this item